These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21600528)

  • 21. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
    Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
    Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term effect of LDL apheresis on coronary heart disease.
    Donner MG; Richter WO; Schwandt P
    Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial hypercholesterolemia].
    Kajinami K; Mabuchi H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):67-72. PubMed ID: 9645010
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of LDL apheresis in the management of hypercholesterolaemia.
    Kitano Y; Thompson GR
    Transfus Sci; 1993 Jul; 14(3):269-80. PubMed ID: 10146338
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V; Wieland E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The apheresis of low-density lipoproteins in homozygous familial hypercholesterolemia].
    Ros Rahola E
    Med Clin (Barc); 1993 Jan; 100(3):117-8. PubMed ID: 8426494
    [No Abstract]   [Full Text] [Related]  

  • 29. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].
    Riesen WF
    Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344
    [No Abstract]   [Full Text] [Related]  

  • 30. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
    Leitersdorf E; Eisenberg S; Eliav O; Friedlander Y; Berkman N; Dann EJ; Landsberger D; Sehayek E; Meiner V; Wurm M
    Circulation; 1993 Apr; 87(4 Suppl):III35-44. PubMed ID: 8462179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of complications and adverse effects of apheresis].
    Yamamoto A; Hatanaka K; Kojima S
    Nihon Rinsho; 1992 Jan; 50 Suppl():388-93. PubMed ID: 1578712
    [No Abstract]   [Full Text] [Related]  

  • 33. [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].
    Konovalov GA; Kukharchuk VV; Sinitsin VV; Trakht IN; Adamova IIu
    Vutr Boles; 1989; 28(4):133-6. PubMed ID: 2596087
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial hypercholesterolaemia: underdiagnosed and undertreated.
    Rees A
    Eur Heart J; 2008 Nov; 29(21):2583-4. PubMed ID: 18840878
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
    Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract]   [Full Text] [Related]  

  • 37. Carotid artery wall shear stress after LDL-apheresis in familial hypercholesterolemia.
    Bardelli M; Cominotto F; Fazio M; Ussi D; Bordin P; Petrucco A; Fabris B; Fischetti F; Lapasin R; Carretta R
    Boll Soc Ital Biol Sper; 1994; 70(10-11):295-7. PubMed ID: 7702833
    [No Abstract]   [Full Text] [Related]  

  • 38. [The plasmoimmunosorption of low-density lipoproteins in the treatment of patients with hereditary hypercholesterolemia].
    Konovalov GA; Pokrovskiĭ SN; Trakht IN; Bokchubaev E; Volkova EI; Kukharchuk VV
    Ter Arkh; 1991; 63(7):65-70. PubMed ID: 1788813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia.
    Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G
    Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.